olmesartan + hydrochlorothiazide/mylan f.c.tab (40+25)mg/tab
mylan pharmaceuticals limited, ireland damastown industrial park, - dublin - olmesartan medoxomil; hydrochlorothiazide - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - (40+25)mg/tab - olmesartan medoxomil 40mg; hydrochlorothiazide 25mg - olmesartan medoxomil and diuretics
olmesartan + hydrochlorothiazide/mylan f.c.tab (40+12.5)mg/tab
mylan pharmaceuticals limited, ireland damastown industrial park, - dublin - olmesartan medoxomil; hydrochlorothiazide - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - (40+12.5)mg/tab - olmesartan medoxomil 40mg; hydrochlorothiazide 12,5mg - olmesartan medoxomil and diuretics
agomelatine/sandoz 25mg/tab επικαλυμμενο με λεπτο υμενιο δισκιο
sandoz pharmaceuticals d.d. (abbr. sandoz d.d.), slovenia (0000011016) verovskova 57, ljubljana, si-1000 - agomelatine - ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ - 25mg/tab - 0138112762 agomelatine 31.171000 mg - agomelatine
tezol 100mg gastro resistant tablet
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - posaconazole - gastro resistant tablet - 100mg - posaconazole (8000002993) 100mg
flucozal 200mg capsule,hard
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - fluconazole - capsule,hard - 200mg - fluconazole (0086386734) 200mg - fluconazole
flucozal 150mg capsule,hard
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - fluconazole - capsule,hard - 150mg - fluconazole (0086386734) 150mg - fluconazole
flucozal 50mg capsule,hard
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - fluconazole - capsule,hard - 50mg - fluconazole (0086386734) 50mg - fluconazole
flucozal 100mg capsule,hard
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - fluconazole - capsule,hard - 100mg - fluconazole (0086386734) 100mg - fluconazole
hemlibra
roche registration limited - emicizumab - Αιμορροφιλία Α - Αντιαιμορραγικά - hemlibra is indicated for routine prophylaxis of bleeding episodes in patients with haemophilia a (congenital factor viii deficiency):with factor viii inhibitorswithout factor viii inhibitors who have:severe disease (fviii < 1%)moderate disease (fviii ≥ 1% and ≤ 5%) with severe bleeding phenotype. hemlibra μπορεί να χρησιμοποιηθεί σε όλες τις ηλικιακές ομάδες.
mhyosphere pcv id
laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - Χοίροι - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.